regulation
Pfizer to call off $160 billion merger with Allergan
April 6, 2016Business Services, Research and Development, Sales and Marketing Allergan, Pfizer, deal, legal, merger and acquisition, regulation
US pharma giant Pfizer Inc (NYSE: PFE) has decided to terminate the $160 billion merger with Botox-maker Allergan Plc (NYSE: …
FTC files complaint against Endo for blocking generics of its pain drugs
April 1, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation
The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …
Lupin drops on FDA observations; company reassures of no disruption at facility
March 29, 2016Business Services, Manufacturing and Production, Sales and Marketing Lupin, US FDA, regulation
Shares of India’s Lupin dropped over 14% Tuesday following news the US Food and Drug Administration (FDA) has made observations …
US govt demands records of Novartis’ educational events in kickbacks suit
March 29, 2016Business Services, Manufacturing and Production, Sales and Marketing Novartis, US government, legal, regulation
Swiss pharma major Novartis (VTX: NOVN) has said the US lawsuit has exploded with the regulators demanding information for about …
Valeant shares slide on SEC investigation announcement
March 1, 2016Manufacturing and Production, Research and Development, Sales and Marketing Philidore, Valeant, regulation
Shares at troubled Valeant plummeted some 20% Monday after the company said it was under investigation by the Securities and …
EU rethinks regulation
December 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Goldacre, Les Rose, MHRA, regulation
What has happened to the science in clinical research? Well, it is still there, but with the explosion in the …
Lords: ‘Simplify pharma regulation’
July 1, 2013Sales and Marketing Lords, NICE, pharma, regulation
Investors are not putting their money into the UK’s regenerative medicine sector because of the high failure rate when it …
Professional regulation – a DIY job?
May 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation
What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
